16.08.2025 02:08

Huajian Medical, a Hong Kong-listed company (01931.HK), has unveiled ambitious plans to invest up to HKD 3 billion in cryptocurrencies over the next three years. This significant allocation will primarily focus on bolstering its Ethereum reserves, a strategic move designed to significantly enhance the capabilities of its Hong Kong-based cryptocurrency exchange, ivd.xyz.

The company's board of directors explicitly stated that this substantial investment is a core component of their overall asset allocation strategy. The aim is twofold: to strengthen the Ethereum treasury held by Huajian Medical and to accelerate the growth and development of the ivd.xyz exchange. This bold decision marks a substantial shift towards cryptocurrency as a key asset class for the company.

This HKD 3 billion investment carries considerable potential implications for the cryptocurrency market, particularly for Ethereum. Increased institutional interest in the digital asset space is likely to follow such a large-scale commitment. While some analysts predict a positive influence on Ethereum's price, others highlight the inherent volatility associated with substantial corporate cryptocurrency investments.

Illustrative of the market impact of large-scale corporate cryptocurrency purchases, recent examples like SharpLink Gaming's acquisition of 52,800 ETH have demonstrably influenced price movements. Currently, according to data from internet sources, Ethereum (ETH) trades at approximately $4,474, boasting a market capitalization of $540 billion and commanding 13.57% market dominance. Recent price performance has been strong, showing a 33% increase over the past 30 days and a remarkable 80.64% rise over the past 90 days. This substantial investment by Huajian Medical could further amplify these trends.